Products

Product Specification

One of the factors driving the growth of the pharmaceutical intermediate market over the forecast period is the increased burden of various diseases such as infectious diseases, chronic diseases, and others. This is expected to cause a surge in the demand for pharmaceutical intermediates over the forecast period. As per the Centers for Disease Control and Prevention 2017 report, there were around 16.8 million physician visits for infectious and parasitic diseases. Various research and development activities carried by pharmaceutical companies will further support the growth of pharmaceutical intermediates market and help companies to expand their therapeutic area segment, which, in turn, will promote the growth of the pharmaceutical intermediate market. Furthermore, patent expiry is also a major factor supporting the growth of the pharmaceutical intermediate market. Moreover, high spending on research and development activities and constant demand for new and innovative therapies are e xpected to promote the growth of pharmaceutical intermediates market over the forecast period. However, stringent regulatory policies are expected to slow down the growth of the pharmaceutical intermediates market in the coming years

Pharmaceutical intermediates are classified on the basis of product type, application, and distribution channel. On the basis of product type, pharmaceutical intermediates market is segmented into GMP and non GMP. On the basis of application, pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. On the basis of the distribution channel, pharmaceutical intermediates are segmented into direct sales and distributors.

The Asia Pacific is expected to be the third largest and fastest growing region over the forecast period, owing to the rise in the occurrence of diseases, increasing investments in healthcare sector and infrastructure, coupled with the increased demand for pharmaceuticals. The developing countries such as China and India have large production units of the pharmaceuticals intermediates and are expected to promote the growth of pharmaceutical intermediate market over the forecast period.

Latin America and the Middle East and Africa pharmaceutical intermediates market is expected to grow moderately over the forecast period due to the increased prevalence of various diseases and increased use of pharmaceuticals. Furthermore, supportive government initiatives are further expected to support the growth of pharmaceutical intermediates in the near future.